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Most DNA double-strand breaks (DSBs) formed in a natural environment have chemical modifications at or near the ends that
preclude direct religation and require removal or other processing so that rejoining can proceed. Free radical-mediated DSBs
typically bear unligatable 3 -phosphate or 3 -phosphoglycolate termini and often have oxidized bases and/or abasic sites near the
break. Topoisomerase-mediated DSBs are blocked by covalently bound peptide fragments of the topoisomerase. Enzymes capable
of resolving damaged ends include polynucleotide kinase/phosphatase, which restores missing 5 -phosphates and removes 3 phosphates; tyrosyl-DNA phosphodiesterases I and II (TDP1 and TDP2), which remove peptide fragments of topoisomerases I
and II, respectively; and the Artemis and Metnase endonucleases, which can trim damaged overhangs of diverse structure. TDP1
as well as APE1 can remove 3 -phosphoglycolates and other 3 blocks, while CtIP appears to provide an alternative pathway for
topoisomerase II fragment removal. Ku, a core DSB joining protein, can cleave abasic sites near DNA ends. The downstream
processes of patching and ligation are tolerant of residual damage and can sometimes proceed without complete damage removal.
Despite these redundant pathways for resolution, damaged ends appear to be a significant barrier to rejoining, and their resolution
may be a rate-limiting step in repair of some DSBs.

1. Introduction
DNA double-strand breaks are extremely toxic DNA lesions
that arise from a variety of sources, including ionizing
radiation [1], radiomimetic drugs [2, 3], oxidative stress
[4, 5], abortive or inhibited topoisomerase reactions [6],
and immunological processes such as V(D)J and class-switch
recombination [7]. Thus, DSB repair is a critical process to
which mammalian cells have devoted enormous resources,
creating a complex network of repair systems that are intricately linked with cell cycle control and survival/death pathways [7]. Remarkably, molecular mechanisms of DSB repair
in mammalian cells almost completely eluded researchers for
decades, until the implication of Ku autoantigen in 1994 [8]
unleashed a cascade of investigations by which the major
players and primary mechanistic details of DSB rejoining
were rather rapidly defined.
Much of the seminal work elucidating these repair
systems has taken advantage of defined DSB substrates,

either constructed in vitro or formed in cells by sitespecific nucleases [9]. These defined DSBs typically have
canonical 5 -phosphate and 3 -hydroxyl termini suitable for
further processing by exonucleases, polymerases, and ligases.
Thus, this experimental approach, while extremely powerful,
bypasses an important step in repair, namely, the cleanup
of the chemically modified termini and/or damaged bases
that accompany most DSBs formed in a natural or clinical
environment. Several enzymes have been described that are
capable of resolving various end modifications, and their
specificity and cofactor requirements have been determined
in some detail. A limited number of studies have been
directed toward distinguishing which of these enzymes are
actually used for repair in cells, and much work remains to be
done in this area. Other cellular studies, however, suggest that
resolution of damaged ends, especially those with complex
or multiple modifications, can be a critical and in some cases
rate-limiting step in repair [10]. This paper will attempt to
summarize current knowledge of the molecular mechanisms
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for resolution of damaged DSB ends in mammalian cells and
the biological consequences of that processing. Studies based
on other organisms such as yeast are included only insofar as
they provide insight into questions for which no comparable
mammalian data are available.

2. Structural Damage at DSB Ends
2.1. Radiation-Induced and Other Free Radical-Mediated
DSBs. DSBs induced by ionizing radiation stem from attack
by free radicals, primarily the hydroxyl radical, on deoxyribose, with formation of carbon-centered free radicals on
any of the five deoxyribose carbons potentially leading to
strand cleavage. Significant free radical-induced blocked
termini include nucleoside 5 -aldehyde on the 5 -side,
and phosphoglycolate (PG), phosphoglycoaldehyde, formyl
phosphate, and 3 -keto-2 -deoxynucleotide on the 3 -side
[1, 11, 12] (Figure 1). Most of these moieties, as well as
most of the free radical-generated oxidized abasic sites, are
unstable and break down spontaneously to leave breaks
with 3 - and 5 -phosphates. A notable exception is the 3 PG, whose stability against further degradation even under
harsh conditions [13] has rendered it the probe of choice
for studies of 3 -end-processing. However, the 2 -oxidized
abasic site is considerably more stable than other abasic
lesions [14], and both this lesion and the 5 -aldehyde [15]
can readily be isolated intact from treated DNAs. The relative
frequencies of the various modified termini are presumably
similar for single versus double strand breaks, but there are
few quantitative data available on this point. An early study
utilizing end-labeled DNA suggested that approximately half
of all radiation-induced breaks bore 3 -PG termini [16], with
3 -phosphates comprising most of the remainder. However,
a more recent measurement by mass spectrometry suggested
a lower 3 -PG incidence of approximately 10% of total sugar
oxidation products [17].
Considerable attention has been devoted recently to
clustered damage induced by “spurs” of closely spaced
ionizations that surround tracks of the secondary electrons
dislodged by γ-rays [25, 26]. Such lesions presumably
contain random mixtures of strand breaks, abasic sites,
and any of the myriad forms of oxidative base damage,
including 8-oxoguanine (8-oxoG) and thymine glycol [1,
27]. Monte Carlo calculations of radiation tracks predict
that a substantial portion of damage sites will harbor
multiple lesions, including DSBs with accompanying nearby
base damage [28, 29]. The primary empirical evidence for
clustered lesions is the generation of additional DSBs in
irradiated DNA or cells by posttreatment with glycosylases
and abasic endonucleases that together cleave sites of base
damage [4, 30]. While these data clearly confirm that
complex lesions do occur, biochemical studies with purified
glycosylases and defined synthetic substrates indicate that
nearby breaks and gaps can block recognition and removal of
damaged bases [31–33], suggesting that glycosylases require
a relatively intact duplex DNA structure on which to act.
Thus, base damages near DNA ends, even if not sequestered
by DSB repair proteins, are likely to be poor substrates for
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repair glycosylases and would instead have to be removed by
DSB-specific mechanisms such as end trimming.
Similar to radiation, the radiomimetic natural products
bleomycin, neocarzinostatin (Zinostatin), and calicheamicin
induce DSBs by free radical mechanisms, but the damage
is largely restricted to the deoxyribose sugar moiety and
to a few specific carbons therein [2, 3]. The Zinostatinand calicheamicin-induced DSBs are similar in chemical
structure but are formed on a 2-base (Zinostatin) and 3base (calicheamicin) 3 -stagger between breaks in opposite
strands. For either compound, one DSB end has a 5 aldehyde and mixture of 3 -phosphate and 3 -PG termini on
a 1-base (Zinostatin) or 2-base (calicheamicin) 3 -overhang.
The opposite DSB end has both 5 - and 3 -phosphate
termini, on a 2-base (Zinostatin) or 3-base (calicheamicin)
3 -overhang. Bleomycin induces DSBs with predominantly
blunt ends or 1-base 5 -overhangs, with predominantly 3 PG termini [34], owing to its specifically targeting oxidation
of the C-4 position, from which 3 -PGs derive [35].
For diﬀusible oxidants such as H2 O2 , strand breaks result
principally from Fenton reactions involving Fe++ ions bound
to DNA [36]. While the chemistry of DNA cleavage is similar
to that seen with radiation, attributable mostly to oxidative
fragmentation of deoxyribose by attack of hydroxyl radicals
[37], there are marked sequence preferences for cleavage,
owing to preferential Fe++ binding at certain sites on DNA
[38]. Presence of at least 25% 3 -PG termini was reported for
strand breaks in DNA from H2 O2 -treated cells [39], and this
fraction would likely be similar for SSBs and DSBs. However,
the initial ratio of SSBs to DSBs is much higher for H2 O2
(∼500 : 1) [40] than for radiation (∼25 : 1) [41]. Thus, most
DSBs in H2 O2 -treated cells result from collision of SSBs with
replication forks. DSBs in nonreplicating G1 cells are much
less frequent but they do occur [5], possibly as a result of
local repetitive redox cycling of DNA-bound Fe++ [36] or by
collision of SSBs with transcription bubbles and subsequent
oxidative or endonucleolytic cleavage of the exposed singlestranded DNA.
2.2. Topoisomerase-Mediated DSBs. DNA topoisomerases I
and II (TOP1 and TOP2) relax DNA by inducing transient
SSBs (TOP1) and DSBs (TOP2) wherein the topoisomerase
is covalently linked through a tyrosine to DNA 3 -phosphate
(TOP1) or 5 -phosphate (TOP2) termini [42, 43]. Normally
the breaks are rapidly rejoined by the topoisomerase with
concomitant dissolution of the tyrosine-DNA covalent bond,
but reversal can be prevented by inhibition or inactivation
of the enzyme, or by oxidative damage to the DNA. In
the case of TOP2 (Figure 2), the irreversible DSB will
then have 3 -hydroxyl termini, and 4-base 5 -overhangs
terminated in a tyrosyl-linked topoisomerase [42]. TOP1mediated DSBs arise primarily by collision of replication
forks with SSBs, resulting in a so-called “one-ended” DSBs
[43]. These DSBs would likely have normal 3 -hydroxyl and
5 -hydroxyl termini and blunt ends if formed from a SSB in
the leading template strand, or 5 -phosphate and 3 -TOP2linked termini, if formed from a SSB in the lagging template
strand, although neither of these structures has been verified
empirically (Figure 3). Moreover, DSBs can also be formed
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Figure 1: Some of the major damaged termini of free radical-mediated DNA strand breaks. (a) 3 -phosphoglycolate (PG). (b) 3 phosphoglycoaldehyde. (c) 3 -formyl phosphate. (d) 3 -keto-2 -deoxynucleotide. (e) 5 -aldehyde.

by a replication-independent but transcription dependent
process, probably involving collision of a transcription
complex with a SSB [6, 44]. These DSBs are correlated
with formation of R-loops (locally denatured DNA segments
with one strand partially annealed to nascent mRNA) in
the wake of arrested transcription complexes. However, the
mechanism by which R-loops promote DSBs is currently
unknown, and thus the structure of these DSBs is diﬃcult
to predict. It is possible that the breaks in both DNA strands
are nucleolytic and occur some distance from the initiating
TOP1-mediated SSB.
Particularly when considering the repair of damage
induced by topoisomerase inhibitors, it is important to
distinguish between irreversible breaks and cleavable complexes. The latter are merely intermediates in DNA relaxation
that are stabilized by the inhibitor [45, 46]. While the DNA
strands in cleavable complexes are indeed broken and are
detected as breaks upon detergent lysis of the cells, they
are rapidly religated by the topoisomerase if instead the
inhibitor is simply removed. When replication forks or
transcription complexes collide with cleavable complexes
that are persistent due to inhibitors, oxidative DNA damage,

or topoisomerase inactivation, proteasomes are recruited
to degrade the topoisomerase [47–50], resulting in an
irreversible break with a topoisomerase fragment linked
to one DNA terminus (Figure 2), which forms the actual
substrate for the end processing enzymes discussed in the
following sections.

3. End Processing Requirements in
Nonhomologous End Joining (NHEJ) and
Homologous Recombination Repair (HRR)
Consideration of the resolution of damaged DSB ends must
take into account the two distinctly diﬀerent mechanisms by
which DSBs are repaired in mammalian cells. In NHEJ, 5 and 3 -termini are in general minimally processed to yield
ends that can be annealed or juxtaposed, then patched and
ligated (Figure 4). Thus, at least one strand must have a 3 hydroxyl terminus suitable for polymerase-mediated extension and ligation on one end and a 5 -phosphate on the other
end. Given the relatively high tolerance of the XRCC4/DNA
ligase IV (X4L4) complex for imperfectly matched ends
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Figure 2: Formation and resolution of TOP2-mediated DSB ends. Proteasome recruitment to a persistent TOP2 cleavable complex results in
digestion of covalently linked TOP2 to a short peptide, which can be removed by TDP2 to leave cohesive ligatable ends that can be accurately
rejoined by NHEJ. Alternatively, CtIP-dependent endonucleolytic cleavage, perhaps catalyzed by MRE11 in its complex with RAD50 and
NBS1 (MRN), can lead to either error-prone NHEJ of the resulting noncohesive ends or to 5 → 3 resection by exonuclease 1, culminating
in HRR.
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Figure 3: Formation of one-ended DSBs by collision of replication forks with persistent TOP1 cleavable complexes. (a) Collision with a
lesion in the leading template strand results in a DSB with both 5 - and 3 -hydroxyl termini, plus a residual 3 -TOP1-terminated SSB. (b)
Collision with a lesion in the lagging template strand results in a one-ended DSB with a TOP1-linked 3 -terminus and an Okazaki fragment
at the 5 -terminus.

(see Section 5), the other strand could in principle bear
unligatable termini (although probably not large adducts),
which could be resolved after ligation of the first strand.
However, at least in some cases, enzymes capable of removing
damaged termini on either recessed or protruding 5 - or 3 single strands would be required. Such terminal processing
could occur at several points in the NHEJ pathway (Figure 5),

for example, even before Ku binding, or after synapsis
and DNA-PK autophosphorylation. Moreover, processing
of blocked termini on the second strand could occur after
ligation of the first strand and dissociation of the NHEJ
repair complex.
HRR, on the other hand, involves extensive exonucleolytic 5 -resection, followed by invasion of a homologous
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Figure 4: Resolution of damaged termini in NHEJ. Ku binds to DNA ends and recruits DNA-PKcs, the XRCC4/DNA ligase IV complex, and
XLF. Synapsis of two DSB ends triggers DNA-PKcs autophosphorylation in trans, inducing a conformational change that allows gap filling
by polymerase λ and finally ligation by DNA ligase IV. Removal of 5 - and 3 -terminal blocks by end processing enzymes can potentially
occur at several steps in the pathway: before recruitment of any NHEJ factors (1); after recruitment of Ku (2) (e.g., by Ku itself [18]); or
after DNA-PKcs autophosphorylation (3), which increases accessibility of the ends. In addition, processing of terminal blocks in the second
strand can occur after ligation of the first strand (4), possibly by SSB repair pathways after dissociation of NHEJ proteins.

sister duplex by the exposed 3 -overhang [51]. In this case,
removal of any 5 -blocks, at both ends of the break, is
essential at a very early step in repair (Figure 5). The strand
invasion step would likely proceed despite small chemical
modifications of the 3 -overhang, although any blocked 3 termini would have to be removed prior to the extension step.

4. DNA End-Processing Enzymes Acting at
Blocked DSB Ends
4.1. Tyrosyl-DNA Phosphodiesterases. Tdp1 was isolated biochemically as a yeast enzyme that removed a protein
fragment of TOP1 from the 3 -end of DNA [52]. The
gene was identified by random mutagenesis [53], and the
corresponding human gene was soon cloned by homology
[54]. In vitro, human TDP1 removes tyrosyl-linked peptides as well as simple tyrosyl moieties from 3 -termini
of either SSBs or DSBs, leaving a 3 -phosphate that can
then be removed by PNKP (see Section 4.3). TDP1 is also
capable of removing other 3 -blocks such as 3 -PGs [55]
and cleaved abasic sites [56], although less eﬃciently than
3 -tyrosyl linkages; for example, human TDP1 removes

3 -phosphotyrosyl moieties about 100 times more eﬃciently
than 3 -PGs [55]. The active site of the enzyme contains
a putative binding channel for single-stranded DNA [57],
suggesting that double-stranded substrates become partially
denatured prior to phosphotyrosyl cleavage. As predicted
from such a model, TDP1 acts more eﬃciently on singlestrand than on double-strand substrates [58] and more
eﬃciently on single-strand 3 -overhangs than on 3 -recessed
ends of DSBs [59].
The extremely rare human genetic disease spinocerebellar ataxia with axonal neuropathy (SCAN1) is associated
with an H493R mutation in TDP1 [60] that reduces the
rate of hydrolysis of tyrosyl-DNA bonds by about 25-fold,
and also dramatically increases the lifetime of a transient
intermediate wherein TDP1 is covalently linked to the DNA
3 -terminus [61]. Despite the leakiness and complexity of
this mutation, these cells provide a model of TDP1 deficiency
for assessing its role in repair of various DNA lesions. TDP1deficient mice, murine embryonic fibroblasts (MEFs) [62–
64], and DT-40 chicken erythrocytes [65] have also been
generated. There is little doubt that TDP1 is instrumental
in removing 3 -linked TOP1 fragments from SSBs, as SSBs
are more persistent in SCAN1 cells than in normal cells after
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Figure 5: Resolution of damaged termini for HRR. In HRR, following its initiation by MRN/CtIP, 5 → 3 exonucleolytic resection
generates 3 -overhangs, one of which invades a sister duplex of the
same sequence. Extension of this 3 -end (dashed line) enlarges the
D-loop until it can be captured by the other 3 -overhang. Extension
of this overhang followed by resolution of crossover structures
restores an intact DNA duplex. Blocked 5 -termini must be removed
before 5→ 3 exonucleolytic resection, probably by CtIP-dependent
endonuclease activity. Removal of blocked 3 -termini could occur
either before or after strand exchange but must occur before the
respective extension steps.

treatment with TOP1 inhibitors [66]. Moreover, TDP1 binds
to DNA ligase III, which carries out the ligation step in SSB
repair [66]. Conversely, there is no evidence of TDP1 binding
to any NHEJ or HRR proteins nor any evidence that TDP1 is
recruited to DSB ends by other DSB repair factors. In fact, in
vitro NHEJ proteins inhibit TDP1 activity toward DNA ends,
probably by restricting access to the termini [59]. As judged
by γH2AX focus-formation assays, there is no detectable
eﬀect of TDP1 deficiency on repair of radiation-induced
DNA DSBs in either SCAN1 cells [67] or MEFs [63]. The
slight sensitivity of SCAN1 cells to radiation is apparently
attributable to a defect in repair of SSBs [67]. Tdp1−/− MEFs
and DT-40 cells [65] as well as SCAN1 cells [68] are sensitive
to the TOP1 inhibitor camptothecin, but this sensitivity is

probably likewise mostly due to a defect in SSB repair, and it
is unclear whether TDP1 is involved in TOP1 removal from
the DSBs.
Nevertheless, Tdp1−/− mice [62] and Tdp1−/− DT-40
cells [65] are both sensitive to bleomycin, while TDP1knockdown HeLa cells are slightly sensitive to calicheamicin
[59]. Moreover, following treatment with calicheamicin,
SCAN1 cells show more chromosome aberrations, particularly dicentric chromosomes, than normal cells [59]. In
extracts of SCAN1 cells [69] and Tdp1−/− MEFs [64], PG
termini on 3 -overhangs of DSBs are highly persistent, with
no detectable processing for several hours, while in extracts
from normal cells, substantial processing can be seen within
minutes. Thus, despite the fact that TDP1’s activity toward
PG termini is about 100 times weaker than toward its
canonical 3 -phosphotyrosyl substrate [55], all these results
suggest a major role for TDP1 in resolution of 3 -PG
termini of DSBs, on both blunt ends and 3 -overhangs. With
calicheamicin in particular, it is unlikely that the observed
sensitivities result from eﬀects on SSB repair, as nearly all
lesions induced by calicheamicin are bistranded [70].
A role for TDP1 in resolution of TOP2-linked DSBs
has been controversial. Neither yeast Tdp1 nor human
TDP1 [71] has any detectable activity toward a simple 5 -phosphotyrosyl oligonucleotide. However, a more
realistic substrate consisting of an oligonucleotide with
phosphotyrosyl-linked peptide, derived from a TOP2 cleavable complex, is cleaved by yeast Tdp1 [72] and less
eﬃciently by human TDP1 (J. L. Nitiss, University of Illinois
college of Pharmacy, personal communication). SCAN1 cells
[68] and Tdp1−/− mice [62] show no sensitivity to TOP2
inhibitors. However, Tdp1−/− DT-40 cells are sensitive to
TOP2 inhibitors [65], while overexpression of TDP1 in 293
cells reduces the level of DNA damage seen after TOP2
inhibitor treatment [73]. Overall, the results suggest that
under some conditions TDP1 can resolve TOP2-linked
DSBs. Apparent species-specific diﬀerences may reflect the
diﬀerences in the eﬃciency of alternative repair pathways for
these lesions.
TDP2, which has no homology to TDP1, has robust
phosphodiesterase activity toward 5 -tyrosyl DNA ends
and much weaker activity toward 3 -tyrosyl ends [71].
Tdp2−/− MEFs and DT-40 cells show significant sensitivity
to TOP2 inhibitors [74, 75]. Thus, TDP2 apparently plays
a major role in resolution of TOP2-linked DSBs (Figure 2),
although increased persistence of TOP2-linked DNA in
TDP2-deficient cells has yet to be directly demonstrated.
4.2. CtIP. CtIP is a critical factor in channeling DSBs to
either the NHEJ or the HRR pathway. In late S and G2 phase,
CtIP phosphorylation at S327 by CDK2 promotes BRCA1
recruitment and the initiation of 5 -resection, which in turn
precludes NHEJ and commits a DSB to repair by HRR [76–
78]. However, CtIP also has modulatory eﬀects on NHEJ
even in G1, where it promotes certain microhomologymediated end joining (MMEJ) events [77]. Sae2, the S.
cerevisiae homologue of CtIP, harbors endonuclease activity
that acts on overhangs near hairpins [79, 80], and it has been
proposed that this activity initiates 5 -resection for HRR by
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endonucleolytically releasing an oligonucleotide (10–40 bp)
from the 5 -end [81]. Such Sae2-dependent cleavage can
most clearly be seen in the processing of SPO11-linked
breaks generated during meiosis [82], and similar cleavage
can be seen in mouse testes, presumably by either an
endonucleolytic activity of CtIP or a CtIP-dependent activity
of MRE11. An initial report of MRE11-dependent CtIP
nuclease activity in vitro [76] has yet to be further elucidated.
Human fibroblasts deficient in either CtIP or MRE11
show a profound deficiency in repair of DSBs induced by
the TOP2 inhibitor etoposide in G1 phase, as judged by
γH2AX focus formation [83]. Similar results were seen when
CtIP was knocked down by siRNA in either fibroblasts
or HeLa cells. Inasmuch as the repair was shown to be
ligase IV-dependent, these results suggest that both CtIP and
the MRE11/RAD50/NBS1 (MRN) complex are required for
NHEJ of TOP2-linked DSBs, most likely reflecting a role in
endonucleolytic removal of the TOP2 peptide from the 5 ends of the DSBs (Figure 2). Remarkably, in these studies
there was virtually no repair in CtIP-knockdown fibroblasts
even as long as 6 hr after treatment. It seems surprising that
TDP2 apparently could not substitute, even partially, for
CtIP in resolving these blocked DSB ends.
CtIP-deficient mouse cells [84] and DT-40 cells [85]
are both inviable. However, DT-40 cells harboring an
unphosphorylatable S332A CtIP allele are viable and
proficient in homologous recombination but are sensitive to both TOP1 and TOP2 inhibitors [85]. Since the
S332A mutation abrogates CtIP binding to Brca1, these
results suggest that Brca1 and CtIP are both required for
endonucleolytic release of both TOP1 and TOP2 fragments
from 3 - and 5 -termini, respectively, of topoisomerasemediated DNA breaks, although again increased persistence
of topoisomerase-linked DNA was not explicitly demonstrated. Curiously, while CtIP(S322A)/Tdp1−/− DT-40 cells
were much more sensitive than either single mutant to
camptothecin, the two mutations were epistatic in conferring
sensitivity to etoposide [65]. These results suggest that CtIP
and Tdp1 are essential factors in a single pathway for
resolution of TOP2 DSBs, a conclusion that is somewhat
diﬃcult to rationalize in terms of their known biochemical
activities. Moreover, the inference that this DSB repair
requires CtIP phosphorylation at S332 (equivalent to human
S327) and CtIP binding to Brca1 is diﬃcult to reconcile with
the human cell studies, wherein cells expressing an S327A
mutant of CtIP had wild-type proficiency in G1 repair of
etoposide-induced DSBs [83].
4.3. Polynucleotide Kinase/Phosphatase (PNKP). PNKP
removes phosphates from 3 -DNA ends and phosphorylates
5 -ends, using ATP as a cofactor [86, 87], but has no other
known activities toward other modified termini, including
3 -PGs [55]. PNKP shows no strict dependence on DNA
secondary structure, acting on simple oligomers, as well as
nicks, gaps, and DSB ends. PNKP binding to XRCC1 [88]
and XRCC4 [89] suggests recruitment to repair complexes
for SSB and DSB repair, respectively, although recruitment to
SSBs does not require and may precede XRCC1 recruitment
[90]. shRNA-mediated knockdown of PNKP in A549
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lung tumor cells confers moderate radiosensitivity [91].
This eﬀect most likely reflects increased persistence of
3 -phosphates.

4.4. Apurinic/Apyrimidinic Endonucleases. Other than apurinic/apyrimidinic (AP) lyases, human cells contain two
known AP endonucleases, APE1 and APE2, that cleave the
phosphodiester bond between the 5 -phosphate of the AP
site and the preceding nucleotide, leaving a 3 -hydroxyl end
[92]. Both enzymes are homologous to E. coli exonuclease
III and have similar activities of AP endonuclease, 3 → 5
exonuclease, and a phosphodiesterase activity that removes
3 -PG and 3 -phosphate termini [92–94]. The canonical and
by far the most eﬃcient activity of APE1 is the cleavage of AP
sites in duplex DNA. APE1 also removes 3 -PGs and other
3 -blocks from DNA ends, although its activity (measured
as kcat /Km ) toward 3 -PGs at internal nicks, recessed 3 -ends,
and blunt ends is 100, 500, and 1800 times lower, respectively,
than its abasic endonuclease activity [95]. Further, APE1
has no activity toward PGs on 3 -overhangs, even 1-base
overhangs. Thus, the substrate preferences of APE1 are
complementary to those of TDP1, which acts more eﬃciently
on overhangs [59].
Studies of APE1 function have been complicated by the
fact that it is essential for survival. Ape1-deficient mice
and MEFs are inviable [96], and conditional Ape1−/− cells
die within days of Ape1 deletion [97]. However, APE1
knockdown renders TK6 lymphoblastoid cells and HCT116
colorectal carcinoma cells more resistant to radiation, but
more sensitive to the radiomimetic agent bleomycin [98].
To explain this paradoxical result, it was proposed that
bleomycin sensitivity reflects a defect in removal of the
predominant 3 -PG moieties at ends of (mostly blunt-ended)
bleomycin-induced DSBs, while radioresistance may result
from fewer complex lesions such as strand breaks with
closely opposed strand breaks being converted to toxic DSBs
when APE1 is knocked down. Thus, these results suggest
that APE1’s phosphodiesterase activity on 3 -PG DSB ends
is biologically significant, despite its ineﬃciency. An early
report of association between APE1 and the core NHEJ
protein Ku [99] has been neither confirmed nor refuted.
APE1 can also remove 3 -phosphotyrosyl moieties from a
recessed 3 -end, but even less eﬃciently than 3 -PGs [100].
APE2 has much weaker AP endonuclease activity than
APE1 [92]. However, it has robust 3 → 5 exonuclease
activity toward mismatched 3 -terminal bases, as well as
3 -PG removal activity [93, 94, 101]. Both activities are
significantly stimulated by proliferating cell nuclear antigen
(PCNA), with which APE2 colocalizes at nuclear foci in cells
following exposure to oxidative stress [101]. Thus, based on
its known activities and its homology to APE1, APE2 is a
candidate enzyme for resolving 3 -PGs and other 3 -blocks,
although its detailed substrate requirements and the kinetic
parameters for various substrates have not been rigorously
defined.
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4.5. Artemis. Artemis was isolated as the factor mutated
in a subset of human severe combined immune deficiency patients with accompanying radiosensitivity (RSSCID) [102]. RS-SCID is also known as Athabascan SCID
(SCID-A), owing to a single mutation detected with relatively
high incidence in Athabascan Amerindians [103]. Artemis
has intrinsic 5 → 3 exonuclease activity (recently suggested
to be a contaminant [104]), but upon complexation with
DNA-PK it acquires an endonuclease activity that opens
DNA hairpins, which are formed as intermediates in V(D)J
recombination. This same activity trims both 3 - and 5 overhangs of DNA DSB ends, usually removing the 5 overhang entirely while shortening 3 -overhangs to 4-5 bases
[105] (Figure 6(a)). However, upon extended incubation,
these short 3 -overhangs are further shortened to 2-3 bases
[106]. Although only DNA-PKcs is strictly required for
Artemis endonuclease activity, Ku enhances activity, especially for less favorable substrates, probably by improving
DNA end binding [106].
Artemis is capable of trimming 3 -PG-terminated overhangs, thus providing a 3 -hydroxyl terminus for patching
and ligation of DSBs, and on shorter overhangs (3–5 bases)
the PG terminus stimulates trimming [106]. Artemis also
coordinately trims both DNA strands at blunt ends, whether
terminated in a 3 -PG or a 3 -hydroxyl [107] (Figure 6(b)).
This process is much slower than the trimming of overhangs
and proceeds via endonucleolytic removal of several bases
from the 5 -terminal strand, followed by trimming of the
resulting 3 -overhang. Whereas the 5 → 3 exonucleolytic
activity of Artemis requires a 5 -phosphate terminus, this
endonucleolytic trimming does not [107].
Thus, based on its biochemical properties, Artemis
could resolve a 3 -PG, and probably any other small 3 modification, in almost any context, including the 3 overhanging PGs of Zinostatin- and calicheamicin-induced
DSBs, as well as blunt-ended bleomycin-induced DSBs.
Consistent with a significant role in DSB repair, RS-SCID
patient-derived Artemis-deficient fibroblasts show increased
sensitivity to Zinostatin, bleomycin, and ionizing radiation
[106], as well as a defect in DSB repair following treatment
with these agents [108]. Moreover, both hypersensitivity and
DSB repair deficiency can be rescued by stable complementation with wild-type Artemis expressed from lentivirus, but
not with endonuclease-deficient mutant of Artemis [108].
These results imply that radiosensitivity in Artemis-deficient
cells reflects a defect in DNA processing, rather than the cell
signaling functions of Artemis.
In principle, Artemis could trim even the most extensively damaged DNA ends, for example, a radiation-induced
DSB with multiple base damages near the end, and trimming
might continue until an undamaged DNA segment is
exposed. Base damage could promote single strandedness
near the DNA end and thus promote Artemis-mediated
cleavage, although these same structural modifications could
have the opposite eﬀect of interfering with substrate recognition.
However, implication of Artemis in trimming of modified DNA ends for DSB repair is complicated by the finding
that the defect in repair is confined to a small fraction of
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the total DSBs, typically 10–20% in the case of radiation or
Zinostatin [108, 109]. According to some studies, in Artemisdeficient cells, these breaks are never repaired, even after
several days, while the other ∼90% of DSBs are repaired
as quickly as in normal cells [110]. The repair-resistant
breaks appear to be primarily those in heterochromatin, and
their repair also requires ATM, the MRE11/RAD50/NBS1
(MRN) complex, and 53BP1. A model has been proposed
wherein both ATM and 53BP1 are required primarily to
phosphorylate the heterochromatin protein KAP-1, resulting
in decondensation of heterochromatin to allow access to
DSB repair factors [109, 111]. Since Artemis and ATM are
epistatic for repair of these slowly rejoined breaks [110], it
may be inferred that Artemis, like ATM, is required only
for repair of breaks in heterochromatin, although this has
not been explicitly shown. Inasmuch as it is unlikely that
the chemistry of the DSBs, especially the relatively welldefined breaks induced by Zinostatin and bleomycin [2,
3], is substantially diﬀerent between heterochromatic and
euchromatic breaks, it is diﬃcult to explain why Artemismediated trimming of the DSB ends would be required
only when the DSB is in heterochromatin. It is possible
that the DSB repair mechanisms for persistent breaks such
as those in heterochromatin are suﬃciently diﬀerent from
those for rapidly repaired breaks and that enzymes which
act on damaged ends are somehow excluded from acting on
the more persistent DSBs. Alternatively, an intriguing study
of DSBs induced at a putative “partially heterochromatic”
DNA locus by the rare-cutting endonuclease I-SceI suggested
that, rather than trimming DNA ends, Artemis excises an
entire DSB-containing nucleosome, thus allowing rejoining
of the more accessible linker regions on either side of that
nucleosome and deletion of the DNA within the nucleosome
[112].
With respect to a role for Artemis in repairing TOP2linked DSBs, there are conflicting data on the eﬀect
of Artemis deficiency on sensitivity to TOP2 inhibitors.
Homologous knockout of Artemis conferred significant
(∼2-fold) etoposide sensitivity to Nalm-6 pre-B cells [113],
while knockout in HCT116 colorectal carcinoma cells had
no eﬀect on sensitivity [112]. RS-SCID patient-derived,
Artemis-deficient fibroblasts showed no defect in rejoining
of etoposide-induced DSBs [110], although in separate study,
similar patient-derived cell lines showed slight sensitivity
to etoposide [114]. A 3 -phosphotyrosyl-terminated 3 overhang was cleaved, albeit rather slowly, by Artemis in
presence of DNA-PK [106], but DNA ends bearing 5 - or
3 -phosphotyrosyl-linked protein fragments (i.e., structural
models of topoisomerase-mediated DSBs) have apparently
not been tested as Artemis substrates.
4.6. Metnase. Metnase, also called SETMAR, has both protein methyltransferase and endonuclease activities and was
discovered in a search for human proteins homologous to
bacterial transposases [115]. Although the nuclease activity
of Metnase does not open DNA hairpins and does not
require any protein cofactors, its specificities are otherwise
remarkably similar to those of Artemis. It is inactive toward
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3
. . .GGAACGCGGAACGCG
. . .CCTTGCCCCTTGCGC
5
Artemis + DNA-PK
. . .GGAACGCGGAACGCG
. . .CCTTGCCCC
TT

Artemis + DNA-PK
. . .GGAACGCGGAA
. . .CCTTGCCCC

(a)

GC
GC

CG
CG

(b)

Figure 6: Trimming of DNA ends by Artemis nuclease. (a) Substrate specificity for trimming of 3 -overhangs. Long overhangs are trimmed
4-5 bases from the single-strand/double-strand junction. Shorter overhangs can be trimmed to as little as 2 bases, but 2 unpaired bases are
required on each side of the cleavage site. A 3 -PG can substitute for the 3 -terminal base. (b) Trimming of blunt ends by Artemis. Several
bases are first removed endonucleolytically from the 5 -terminal strand (which can be either phosphate- or hydroxyl terminated), generating
a 3 -overhang that is then also trimmed, whether it is terminated in a 3 -PG (•) or a 3 -hydroxyl. All endonucleolytic trimming by Artemis
requires autophosphorylated DNA-PK.

intact double-stranded DNA, but it trims both 5 - and
3 -overhangs of DSBs, as well as flaps and Y-structures
mimicking frayed DSB ends [116]. It appears to require
a free 5 - or 3 -DNA terminus for entry, as it does not
cleave single-stranded loops flanked at both ends by doublestranded regions. Its methyltransferase activity promotes
NHEJ, at least in part by methylating histone H3 at Lys36
[117]. However, its activity in stimulating and improving
the fidelity of end joining of transfected plasmid substrates
is dependent on its nuclease activity [118]. Thus, given
its biochemical specificity, its binding to XRCC4, and its
implication in NHEJ, Metnase is a candidate for trimming
diverse types of damage to DNA ends, thereby creating
substrates more amenable to patching and ligation. However,
its activity toward damaged ends has yet to be explicitly
investigated.
4.7. Exonucleases. Mammalian cells contain a variety of 3→
5 and 5 → 3 exonucleases that could in principle serve
to remove terminal modifications, similar to exonuclease
III in E. coli [119]. However, relatively few mammalian
exonucleases have been tested for activity toward terminally
modified substrates and those that have shown little such
activity. The major 3 → 5 exonuclease activity in mammalian cell extracts is DNAse III [120], also called TREX1.
Exonucleolytic digestion of DNA by DNAse III is completely
blocked by a 3 -PG terminus, in either the presence or
absence of Ku [121] or by a 3 -phosphotyrosyl terminus
[100]. Its crystal structure revealed a tight nucleotide binding
pocket that would be unlikely to either accommodate the
extra bulk of a terminal PG or recognize the PG itself as a
terminal nucleotide [122]. The Werner syndrome-associated
protein WRN1, which binds to both Ku and XRCC4 [123]
(suggesting some role in NHEJ), likewise has no activity
toward either 3 -PG or 3 -phosphotyrosyl substrates [100].

Other mammalian 3 → 5 exonucleases, including RAD9
[124] and MRE11 [125] (which is strongly implicated in
both NHEJ and HRR), do not appear to have been tested for
activity toward modified termini.
Mammalian 5→ 3 exonucleases include Apollo (SNM1B,
DCLRE1B), Artemis (SNM1C, DCLRE1B, discussed above),
aprataxin, exonuclease 1 (EXO1), Fanconi-associated nuclease 1 (FAN1), flap endonuclease 1 (FEN1), and the
aprataxin-and-PNKP-like factor (APLF, PALF) [126–128].
Aprataxin has been implicated in resolution of abortive
5 -adenylated ligase intermediates for both SSB repair and
NHEJ [129]. In general, the 5 → 3 exonuclease function
of the other enzymes either requires or strongly prefers a
5 -phosphate. Apollo, Artemis (discussed above), Aprataxin,
exonuclease I, and PALF all have single-strand endonuclease
activity as well that could in principle resolve either 3 - or 5 terminal blocks. However, except for Artemis and aprataxin,
there is only indirect evidence that resolution of damaged
termini is a biologically relevant function of these enzymes
in cells. PALF binds to XRCC4 and can trim 3 -overhangs to
promote end joining in a defined in vitro NHEJ system based
on purified recombinant proteins [130]. Fen-1 has been
implicated in resolution of flap structures for NHEJ in yeast
[131], but there is no comparable evidence in mammalian
cells. Thus, overall there is little evidence for exonucleolytic
removal of 5 -blocks. The mechanism by which the 5 aldehyde termini of Zinostatin- and calicheamicin-induced
DSBs are resolved is essentially unknown. One possibility
is release of a 5 -terminal oligonucleotide by CtIP (see
Section 4.2). Alternatively, as 5 -aldehydes are formed in
only one strand of these DSBs, they could be removed by
displacement synthesis following religation of the break in
the complementary strand (see Section 5).
4.8. Ku. Ku is a heterodimer that forms a basket-shaped
structure whose “handle” threads onto DNA ends, making

tight contact with the DNA grooves [132]. Once bound
to a DNA end, Ku recruits other NHEJ factors [133] and
stimulates the final religation step [134]. Ku also has a potent
lyase activity that serves to cleave abasic sites near DNA
ends [18]. This lyase activity also removes deoxyribose-5phosphate moieties such as would be present at one 5 terminus of a DSB formed by APE1-mediated cleavage of
an AP site near a closely opposed strand break. Although
lyase activity might be expected for any protein whose basic
amine residues are in tight contact with DNA grooves,
the lyase activity of Ku shows specificities which suggest
that it may be specifically adapted to promote eﬃcient and
accurate NHEJ [135]. For example, it is more active toward
AP sites on 5 -overhangs, where it would generate ligatable
5 -phosphates than on 3 -overhangs where a nonligatable
cleaved sugar moiety would be left blocking the 3 -terminus.
In addition, AP sites which are suﬃciently distant from
a terminus such that ligation can still occur despite their
presence are relatively resistant to Ku’s lyase activity. In
other words, Ku appears to cleave AP sites preferentially in
situations where doing so would facilitate end joining or
increase its accuracy, whereas cleavage is suppressed when it
would lead to unnecessary deletion of terminal nucleotides
prior to religation.

5. Damage Tolerance in NHEJ
Like all DNA ligases, the NHEJ-associated DNA ligase IV has
an absolute requirement for 5 -phosphate and 3 -hydroyxl
termini. However, in its usual tight complex with XRCC4,
ligase IV has considerable tolerance for ends that are not perfectly matched and overhangs that are not perfectly annealed.
For example, short, partially complementary overhangs can
be annealed and ligated despite the presence of singlestranded flaps, mismatched bases, and missing nucleotides
in the presumed annealed segment (Figure 7). Moreover, the
eﬃciency of ligation of imperfectly matched ends is increased
markedly by the presence of XLF [20, 136, 137], a scaﬀold
protein that forms filaments of alternating homodimers with
XRCC4. In vitro, the combination of X4L4, Ku, DNA-PKCS,
and XLF can join two ends with completely mismatched
overhangs, albeit only in one strand (Figure 7(b)), and
can also join a protruding 5 -overhang to a blunt end
(not shown) [20]. The gap-filling NHEJ-associated DNA
polymerase λ displays a similar tolerance for imperfectly
annealed template/primers [138, 139]. While ligases and
polymerases could in principle have higher stringency in the
context of a full repair complex than when acting alone on
a DNA substrate in vitro, end joining experiments in both
extracts and intact cells confirm that ligation of mismatched
overhangs can occur. For example, in Chinese hamster ovary
(CHO) cells, end joining of two-ATAA 3 -overhangs of ISceI-induced DSBs apparently proceeds predominantly by
annealing the two terminal TAA trinucleotides to each other
(despite the internal A•A mismatch), followed by single-base
gap filling and ligation (Figure 7(c)) [21]. Further studies in
human cell extracts supplemented with an extremely errorprone mutant form of polymerase λ likewise show that
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ACAAAATA
TGTTTTAT

AGGTACCG
TCTCGAGC

GGATAATCC
CCTAATAGG

(a)

(b)

(c)

CGACGTCG
GCTGCAGC

TTGCCGG CGTGCGTCG
AACGGCCTGCGCGCAGC
(d)

G = 8-oxoG

(e)

CGACGTCG
GC GCAGC

• = 3 -PG

(f)

Figure 7: Tolerance for mismatched and damaged ends in patching
and ligation for NHEJ. Black text shows sequences of ends prior to
joining, while blue text shows fill-in of bases by DNA polymerase
λ. Lines above and below the text represent the DNA backbone,
triangles show sites of ligation by X4L4, and red bars between the
bases show mismatches. All sequences read 5→ 3 in the top strand
and 3 → 5 in the bottom strand. (a) Cohesive overhangs with
an unpaired 3 -flap, ligated by X4L4 alone [19]. (b) Completely
mismatched overhangs ligated in one strand only, by purified
X4L4 plus Ku, DNA-PKcs, and XLF in vitro [20]. (c) Patching
and ligation of annealed overhangs of two I-SceI-induced DSBs
in hamster cells, despite an internal A-A mismatch, inferred from
sequencing of repair joints [21]. (d) Ligation of a mismatched
duplex resulting from error-prone fill-in in HeLa cell extracts
supplemented with X4L4 and a highly error-prone mutant of
polymerase λ [22]. The single dash in the top strand sequence
indicates a single-base deletion. (e) Patching and ligation of partially
complementary overhangs, one of which contains a 3 -terminal
8-oxoG, in X4L4-supplemented HeLa nuclear extracts [23]. (f)
Patching and ligation of partially complementary overhangs in
one strand, despite persistence of a 3 -PG-terminated break in the
opposite strand, also in X4L4-supplemented HeLa nuclear extracts
[24].

repair patches containing multiple mismatches can be ligated
during NHEJ (Figure 7(d)) [22].
By analogy, it is likely that similar patching and ligation
can occur even on ends that contain some degree of base
damage and other modifications at or very near DNA
termini. A few studies using defined substrates that incorporate such damage support this proposal. For example,
similar to the -ATAA overhangs mentioned above, a substrate
bearing at an -ACG 3 -overhang on one end and an AC(8-oxoG) overhang at the other, can be annealed at the
terminal dinucleotides, patched and ligated (Figure 7(e)). In
this cell extract-based NHEJ model, the 8-oxoG-containing
strand clearly undergoes polymerase λ-dependent singlebase extension and ligation without prior removal of the
damaged base [23]. However, presence of 8-oxoG on both
overhangs appeared to block this process. Likewise, the
nonplanar base thymine glycol suppressed patching and
ligation of partially complementary -CTA overhangs by at
least 90% [23].
This same in vitro system was able to join two ends, one
with a PG-terminated -ACG 3 -overhang and one with an
identical but hydroxyl-terminated overhang (Figure 7(f)). In
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this case, the hydroxyl-terminated strand was often patched
and ligated, without any processing of the 3 -PG-terminated
complementary strand [24]. With this substrate, the second,
3 -PG-terminated break could likely be repaired at a later
time by the less error-prone base excision and SSB repair
pathways. Similar postend-joining repair of residual damage
could also occur for the DSB substrates containing abasic
sites and damaged bases, presumably in a relatively errorfree manner. Thus, in all these cases, tolerance for residual
damage in end joining could actually increase fidelity,
because a less tolerant system might require endonucleolytic
trimming of these damaged ends, resulting in deletion of
terminal nucleotides in the repaired products.
In a diﬀerent extract-based end joining assay, either
8-oxoG or a base mismatch at the penultimate base pair
of a blunt-ended DSB was found to strongly inhibit end
joining, while an abasic site the same position blocked
joining entirely [140]. Although the specific substrates used
were not identical, this experimental system appears to show
somewhat less tolerance for nearby mismatches, abasic sites,
and base damage than those mentioned above. Nevertheless,
end joining products that retained damaged bases or base
mismatches were detected in this system as well.

6. Perspectives
Overall, mammalian cells are seen to harbor multiple
redundant pathways and enzymes for resolution of damaged
DSB ends, with diverse specificities and various degrees
of sequence conservation. Much remains to be determined
regarding which mechanisms predominate under particular
circumstances and how the various pathways are prioritized
in the cell. Experimentally, a major obstacle to addressing
these issues is the lack of assays capable of tracking DSB end
processing in intact cells. Technologies to induce terminally
modified DSBs at a defined time and at specific sites would be
very helpful in this regard. While chemical techniques such
as mass spectrometry are still far too insensitive to be used
to follow DSB end processing, continuing improvements
and adaptations may yet make such direct chemical analysis
tractable.
With respect to therapeutic implications, the most obvious application would be to identify inhibitors that would
block end processing and thereby enhance the antitumor
activity of DSB-inducing cancer chemotherapeutic agents.
Given the redundancy of end processing pathways outlined
above, resolution of damaged ends might seem an unlikely
target for inhibition. Nevertheless, despite apparent redundancy, some of the single mutants, such as the Tdp2−/− DT40 cells and MEFs [74, 75], do show significant sensitivity to
certain types of DSBs. Given the general tendency of cancer
cells to lose proficiency in one or more repair systems, there
is reason to hope that at least for select classes of tumors,
such sensitization might be induced selectively in tumor cells,
while having less eﬀect on fully repair-competent normal
cells.
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Löbrich, “CtIP and MRN promote non-homologous endjoining of etoposide-induced DNA double-strand breaks in
G1,” Nucleic Acids Research, vol. 39, no. 6, pp. 2144–2152,
2011.
P. L. Chen, F. Liu, S. Cai et al., “Inactivation of CtIP leads
to early embryonic lethality mediated by G1 restraint and
to tumorigenesis by haploid insuﬃciency,” Molecular and
Cellular Biology, vol. 25, no. 9, pp. 3535–3542, 2005.
K. Nakamura, T. Kogame, H. Oshiumi et al., “Collaborative
action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent
break repair,” PLoS Genetics, vol. 6, no. 1, Article ID
e1000828, 2010.
F. Karimi-Busheri, G. Daly, P. Robins et al., “Molecular characterization of a human DNA kinase,” Journal of Biological
Chemistry, vol. 274, no. 34, pp. 24187–24194, 1999.
A. Jilani, D. Ramotar, C. Slack et al., “Molecular cloning of
the human gene, PNKP, encoding a polynucleotide kinase 3 phosphatase and evidence for its role in repair of DNA strand
breaks caused by oxidative damage,” Journal of Biological
Chemistry, vol. 274, no. 34, pp. 24176–24186, 1999.
C. J. Whitehouse, R. M. Taylor, A. Thistlethwaite et al.,
“XRCC1 stimulates human polynucleotide kinase activity at
damaged DNA termini and accelerates DNA single-strand
break repair,” Cell, vol. 104, no. 1, pp. 107–117, 2001.
C. A. Koch, R. Agyei, S. Galicia et al., “Xrcc4 physically
links DNA end processing by polynucleotide kinase to DNA
ligation by DNA ligase IV,” EMBO Journal, vol. 23, no. 19, pp.
3874–3885, 2004.
J. Della-Maria, M. L. Hegde, D. R. McNeill et al., “The
interaction between polynucleotide kinase phosphatase and
the DNA repair protein XRCC1 is critical for repair of DNA
alkylation damage and stable association at DNA damage
sites,” Journal of Biological Chemistry, vol. 287, no. 46, pp.
39233–39244, 2012.
A. Rasouli-Nia, F. Karimi-Busheri, and M. Weinfeld, “Stable

[92]

[93]

[94]

[95]

[96]

[97]

[98]

[99]

[100]

[101]

[102]

[103]

[104]

[105]

down-regulation of human polynucleotide kinase enhances
spontaneous mutation frequency and sensitizes cells to
genotoxic agents,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 101, no. 18, pp.
6905–6910, 2004.
M. Z. Hadi and D. M. Wilson III, “Second human protein
with homology to the Escherichia coli abasic endonuclease
exonuclease III,” Environmental and Molecular Mutagenesis,
vol. 36, no. 4, pp. 312–324, 2000.
M. Z. Hadi, K. Ginalski, L. H. Nguyen, and D. M. Wilson,
“Determinants in nuclease specificity of Ape1 and Ape2,
human homologues of Escherichia coli exonuclease III,”
Journal of Molecular Biology, vol. 316, no. 3, pp. 853–866,
2002.
P. Burkovics, V. Szukacsov, I. Unk, and L. Haracska, “Human
Ape2 protein has a 3 -5 exonuclease activity that acts
preferentially on mismatched base pairs,” Nucleic Acids
Research, vol. 34, no. 9, pp. 2508–2515, 2006.
D. Suh, D. M. Wilson, and L. F. Povirk, “3 Phosphodiesterase activity of human apurinic/apyrimidinic
endonuclease at DNA double-strand break ends,” Nucleic
Acids Research, vol. 25, no. 12, pp. 2495–2500, 1997.
S. Xanthoudakis, R. J. Smeyne, J. D. Wallace, and T. Curran,
“The redox/DNA repair protein, Ref-1, is essential for early
embryonic development in mice,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 93,
no. 17, pp. 8919–8923, 1996.
T. Izumi, D. B. Brown, C. V. Naidu et al., “Two essential but
distinct functions of the mammalian abasic endonuclease,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 102, no. 16, pp. 5739–5743, 2005.
H. Fung and B. Demple, “Distinct roles of Ape1 protein in
the repair of DNA damage induced by ionizing radiation or
bleomycin,” Journal of Biological Chemistry, vol. 286, no. 7,
pp. 4968–4977, 2011.
U. I. Chung, T. Igarashi, T. Nishishita et al., “The interaction
between Ku antigen and REF1 protein mediates negative
gene regulation by extracellular calcium,” Journal of Biological
Chemistry, vol. 271, no. 15, pp. 8593–8598, 1996.
J. A. Harrigan, J. Fan, J. Momand, F. W. Perrino, V. A. Bohr,
and D. M. Wilson, “WRN exonuclease activity is blocked by
DNA termini harboring 3 obstructive groups,” Mechanisms
of Ageing and Development, vol. 128, no. 3, pp. 259–266, 2007.
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